Pendal Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$222M Sell
432,785
-38,588
-8% -$19.8M 1.92% 11
2022
Q3
$214M Buy
471,373
+39,549
+9% +$18M 2.08% 11
2022
Q2
$208M Buy
431,824
+209,746
+94% +$101M 2.05% 11
2022
Q1
$109M Buy
222,078
+44,238
+25% +$21.7M 0.9% 43
2021
Q4
$82.4M Sell
177,840
-66,216
-27% -$30.7M 0.66% 49
2021
Q3
$91M Buy
244,056
+1,328
+0.5% +$495K 0.75% 51
2021
Q2
$92.7M Buy
242,728
+239,378
+7,146% +$91.4M 0.85% 47
2021
Q1
$1.2M Sell
3,350
-922
-22% -$331K 0.01% 292
2020
Q4
$1.37M Sell
4,272
-12,121
-74% -$3.89M 0.01% 254
2020
Q3
$4.4M Buy
16,393
+3,469
+27% +$932K 0.05% 105
2020
Q2
$3.4M Buy
12,924
+1,603
+14% +$422K 0.05% 130
2020
Q1
$2.57M Sell
11,321
-10,358
-48% -$2.35M 0.04% 138
2019
Q4
$6.55M Buy
21,679
+19,872
+1,100% +$6M 0.09% 111
2019
Q3
$434K Sell
1,807
-35,920
-95% -$8.62M 0.01% 366
2019
Q2
$10.6M Sell
37,727
-6,856
-15% -$1.93M 0.15% 71
2019
Q1
$12.8M Hold
44,583
0.18% 67
2018
Q4
$11.7M Buy
44,583
+9,727
+28% +$2.55M 0.19% 76
2018
Q3
$9.55M Sell
34,856
-1,809
-5% -$496K 0.13% 94
2018
Q2
$8.73M Sell
36,665
-8,989
-20% -$2.14M 0.11% 120
2018
Q1
$10M Hold
45,654
0.13% 113
2017
Q4
$10.3M Buy
45,654
+10,109
+28% +$2.27M 0.13% 116
2017
Q3
$6.76M Sell
35,545
-7,370
-17% -$1.4M 0.09% 151
2017
Q2
$8.07M Buy
+42,915
New +$8.07M 0.12% 134